Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles N Ellis

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Journal of the American Academy of Dermatology|February 7, 2012
Novel systemic drugs under investigation for the treatment of psoriasisJohann E Gudjonsson, Andrew Johnston, Charles N Ellis
Drugs|June 23, 2009
Ustekinumab: a new option in psoriasis therapyAnna L Chien, James T Elder, Charles N Ellis
Archives of Dermatology|July 19, 2006
Academia is the life for me, I'm sureKevin F Kia, Robert A Gielczyk, Charles N Ellis
Journal of the American Academy of Dermatology|March 22, 2002
Sulfasalazine for alopecia areataCharles N Ellis, Margaret F Brown, John J Voorhees
Skinmed|November 9, 2005
Improvement in psoriasis with rosiglitazone in a diabetic and a nondiabetic patientHarrihar A Pershadsingh, Steven C Benson, Charles N Ellis
American Journal of Clinical Dermatology|January 30, 2003
Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trialCharles N Ellis, Margaret M Mordin, Ellen Y Adler, et al.
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Quantifying costs associated with atopic dermatitisCharles N Ellis, Mary M Prendergast, Michael Tokar, et al.
American Journal of Clinical Dermatology|April 12, 2006
Cost effectiveness of management of mild-to-moderate atopic dermatitis with 1% pimecrolimus cream in children and adolescents 2-17 years of ageCharles N Ellis, Kristijan H Kahler, Jens Grueger, et al.
Expert Opinion on Investigational Drugs|October 17, 2006
Thiazolidinediones: potential as therapeutics for psoriasis and perhaps other hyperproliferative skin diseaseJames Varani, Narasimharao Bhagavathula, Charles N Ellis, et al.
JAAD International|October 2, 2023
High rate of incidental detection of skin cancer following teledermatology consultation: Full body skin examination may detect more skin cancers than a referral-based approachTrilokraj Tejasvi, Nicole Trupiano, Thomas Scharnitz, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Journal of the American Academy of Dermatology|February 7, 2012
Novel systemic drugs under investigation for the treatment of psoriasisJohann E Gudjonsson, Andrew Johnston, Charles N Ellis
Drugs|June 23, 2009
Ustekinumab: a new option in psoriasis therapyAnna L Chien, James T Elder, Charles N Ellis
Archives of Dermatology|July 19, 2006
Academia is the life for me, I'm sureKevin F Kia, Robert A Gielczyk, Charles N Ellis
Journal of the American Academy of Dermatology|March 22, 2002
Sulfasalazine for alopecia areataCharles N Ellis, Margaret F Brown, John J Voorhees
Skinmed|November 9, 2005
Improvement in psoriasis with rosiglitazone in a diabetic and a nondiabetic patientHarrihar A Pershadsingh, Steven C Benson, Charles N Ellis
American Journal of Clinical Dermatology|January 30, 2003
Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trialCharles N Ellis, Margaret M Mordin, Ellen Y Adler, et al.
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Quantifying costs associated with atopic dermatitisCharles N Ellis, Mary M Prendergast, Michael Tokar, et al.
American Journal of Clinical Dermatology|April 12, 2006
Cost effectiveness of management of mild-to-moderate atopic dermatitis with 1% pimecrolimus cream in children and adolescents 2-17 years of ageCharles N Ellis, Kristijan H Kahler, Jens Grueger, et al.
Expert Opinion on Investigational Drugs|October 17, 2006
Thiazolidinediones: potential as therapeutics for psoriasis and perhaps other hyperproliferative skin diseaseJames Varani, Narasimharao Bhagavathula, Charles N Ellis, et al.
JAAD International|October 2, 2023
High rate of incidental detection of skin cancer following teledermatology consultation: Full body skin examination may detect more skin cancers than a referral-based approachTrilokraj Tejasvi, Nicole Trupiano, Thomas Scharnitz, et al.
Pageof 5